Linked Life Data

7482815

Source:http://linkedlifedata.com/resource/pubmed/id/7482815

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5 Suppl 1
pubmed:dateCreated
1995-12-1
pubmed:abstractText
Recurrent CMV disease has been reported to occur in 6% to 59% of solid-organ transplant recipients. The consequences of recurrent CMV disease after the treatment of the first CMV disease episode in patient and graft survival have not been fully elucidated. Additionally, few epidemiologic data are available regarding predictors of recurrent CMV disease. In three of four studies that investigated predictors for recurrent CMV disease, primary CMV infection (D+/R-) was associated with a higher rate of recurrent CMV disease among liver, intestinal, and solid-organ transplant recipients in general. Antirejection therapy was associated with recurrent CMV disease in two of three studies that examined this variable as a possible predictor of recurrent CMV disease. Further studies are needed to define the subgroup of solid-organ transplant recipients at higher risk for recurrent CMV disease, for whom more intensive or novel prophylactic, therapeutic, or diagnostic cost-effective strategies are warranted.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0041-1345
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
34-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Recurrent cytomegalovirus disease in solid-organ transplant recipients.
pubmed:affiliation
Department of Medicine and Pathology, New England Medical Center, Boston, Massachusetts 02111, USA.
pubmed:publicationType
Journal Article, Comparative Study, Review